Timing of supplemental parenteral nutrition in critically ill adults
Official title: The Effect of the Timing of Supplemental Parenteral Nutrition on the Prognosis of Critically Ill Patients (T-SPN): A Multicenter Randomized Controlled Trial
Run by The First Hospital of Jilin University · NCT07085455 · Data updated 2026-11-12
This trial will test whether starting supplemental parenteral (intravenous) nutrition on day 4 versus day 8 after ICU admission reduces 28-day death in critically ill adults who cannot meet calorie needs with enteral feeding.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 946 (estimated) |
| Sponsor | The First Hospital of Jilin University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 2 sites (Changchun, Jilin and 1 other locations) |
| Status | Recruiting |
| Started | September 9, 2025 |
| Main results expected | July 20, 2027 |
| Study ends | July 20, 2029 |
| Registry record updated | September 15, 2025 |
| Trial ID | NCT07085455 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with at least one organ failure (SOFA ≥2) within 24 hours of ICU admission, expected to remain in the ICU >72 hours, able to start enteral nutrition within 48 hours but receiving <50% of target calories within 72 hours are eligible.
✕Probably not a fit
Patients who can tolerate full oral or full-dose enteral nutrition, those expected to die within 72 hours, pregnant or lactating women, or those with contraindications to parenteral nutrition are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter randomized controlled trial will assign critically ill adult ICU patients who are unable to reach 50% of their caloric needs by enteral nutrition to receive supplemental parenteral nutrition (SPN) beginning on day 4 versus day 8 after ICU admission. The primary outcome is 28-day all-cause mortality, with secondary outcomes including mortality at multiple time points through two years, 2-year EQ-5D-5L functional status, ICU length of stay, nutritional markers (prealbumin), muscle mass measurements, ICU-acquired infections, ventilator-free days, and metabolic adverse events. Baseline demographic, severity (APACHE II, SOFA) and nutritional data are collected within 24 hours of ICU admission and relevant clinical data are recorded throughout the ICU stay. The trial is conducted at participating ICUs with standardized protocols for enteral feeding, SPN administration, and outcome measurement.
Why it matters
Potential benefit: If successful, earlier supplemental parenteral nutrition could reduce short-term mortality and help preserve muscle and long-term functional outcomes by preventing prolonged energy deficits.
How similar studies have gone: Previous randomized trials of early versus delayed supplemental parenteral nutrition have produced mixed results—some showing no mortality benefit or increased complications—so the specific day-4 versus day-8 timing with detailed long-term functional and muscle endpoints is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥ 18 years 2. Failure of one or more organ systems within 24 hours of ICU admission, defined as Sequential Organ Failure Assessment (SOFA) score ≥ 2 in any single organ system 3. Expected ICU stay \> 72 hours 4. Able to initiate early enteral nutrition (EN) within 48 hours of ICU admission 5. Enteral nutrition providing \<50% of target caloric requirements within 72 hour Exclusion Criteria 1.Full oral intake or tolerance of full-dose EN; no need for SPN 2.Receiving palliative care or expected to die within 72 hours 3.Pregnant or lactating women 4.Long-term use of systemic corticosteroids or other immunosuppressive agents 5.Known malignancy currently receiving radiotherapy or chemotherapy 6.Contraindications to parenteral nutrition (PN) 7.Participation in another interventional clinical trial
Where it's running
-
The First Hospital of Jilin University
Changchun, Jilin, China Recruiting -
The First Hospital of Jilin University
Changchun, Jilin, China Not yet recruiting
Study contacts
- Study coordinator: yanhua li
- Email: liyanhua@jiu.edu.cn
- Phone: 86-15804301738
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using gut blood flow measurements to predict feeding intolerance in critically ill adults
This study will test whether bedside ultrasound measurements of gastrointestinal blood flow can help predict which critically ill adults receiving enteral nutrition will develop feeding intolerance.
-
Predicting Extubation Problems With Machine Learning
This study tests whether computer models can predict extubation failure in adults on ventilators in the ICU.
-
Levetiracetam Dosing in Critically Ill on CRRT
This study tests how levetiracetam behaves in the bodies of adults on continuous renal replacement therapy to help figure out the best dosing.
-
Respiratory Physiotherapy in Critically Ill Pneumonia Patients
This study tests whether a structured breathing and chest therapy program can change inflammatory biomarkers in adults with pneumonia in the ICU compared to usual care.
-
Immersive VR for improving upper limb function in critically ill ICU patients
This trial tests whether fully immersive virtual reality training added to standard ICU rehabilitation can help improve upper limb strength and coordination in adults with ICU-acquired weakness.
-
Cycling with immersive VR for ICU patients recovering from critical illness
In this crossover study, critically ill adults in the ICU will try three 10-minute cycling sessions to see if an immersive VR environment motivates them more than cycling with no visuals or cycling while watching a route on a TV.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.